Alvotech (ICE:ALVO)
Iceland
· Delayed Price · Currency is ISK 1,090.00
-15.00 (-1.36%)
At close: Apr 16, 2025
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
67.19M ISK
Profits / Employee
-31.66M ISK
Market Cap
319.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marel | 7,500 |
| Íslandsbanki | 764 |
| Arion banki | 822 |
| Sildarvinnslan Hf. | 723 |
| Brim hf. | 694 |
| Hagar | 2,699 |
| Kvika banki | 270 |
| Festi | 1,352 |
Alvotech News
- 21 days ago - This Is a Test From GlobeNewswire - GlobeNewsWire
- 22 days ago - Alvotech (ALVO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer - GlobeNewsWire
- 23 days ago - Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer - GlobeNewsWire
- 23 days ago - Alvotech Reports Record Results for 2024 and Provides Business Update - GlobeNewsWire
- 23 days ago - Alvotech Reports Record Results for 2024 and Provides Business Update - GlobeNewsWire
- 24 days ago - UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab) - GlobeNewsWire
- 24 days ago - UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab) - GlobeNewsWire